PFE's new CEO has done a good job so far. It seems he has a little bit more clarity what he wants PFE to be. PFE getting out of cardiovascular area didn't make any sense to me. Cardiovascular is a big market, and it is big pharma's job.
Market Data 
Markets 
AI
